Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter 2024 Financial Results on August 8
DUBLIN, Aug. 01, 2024 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq:AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 8:30 a.m. ET on Thursday, August 8, 2024, to provide a corporate update and discuss the Company’s financial results for the second quarter ended June 30, 2024.